Abstract:De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly developing fields with lead candidate discovery in the drug development process. First, artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This article explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence. However, the hybrid quantum-classical GANs still face challenges in generating unique and valid molecules compared to their classical counterparts.

Invited: Drug Discovery Approaches using Quantum Machine Learning

Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries

Quantum Machine Learning for Drug Discovery

Quantum Generative Models for Small Molecule Drug Discovery

Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry

Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery

Insight into Quantum Computing and Deep Learning Approach for Drug Design

Unlocking the Potential of Quantum Machine Learning to Advance Drug Discovery

Quantum Machine Learning Algorithms for Drug Discovery Applications

Scalable Variational Quantum Circuits for Autoencoder-based Drug Discovery

Quantum-machine-assisted Drug Discovery: Survey and Perspective

Implementation of The Future of Drug Discovery: QuantumBased Machine Learning Simulation (QMLS)

Quantum Long Short-Term Memory for Drug Discovery

Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

Machine learning-aided generative molecular design

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Hybrid quantum-classical machine learning for generative chemistry and drug design

Generative chemistry: drug discovery with deep learning generative models

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Quantum Computing for Near-Term Applications in Generative Chemistry and Drug Discovery.

Quantum machine learning framework for virtual screening in drug discovery: a prospective quantum advantage